Cannabinoid Receptor Signaling 79Varma N, Carlson GC, Ledent C, Alger BE (2001) Metabotropic glutamate receptors drive
the endocannabinoid system in hippocampus. J Neurosci 21:RC188
VasquezC,LewisDL(1999)TheCB1cannabinoidreceptorcansequesterG-proteins,making
them unavailable to couple to other receptors. J Neurosci 19:9271–9280
Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R (1993) Anandamide, a brain
endogenous compound, interacts specifically with cannabinoid receptors and inhibits
adenylate cyclase. J Neurochem 61:352–355
Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ (1995) The MAP kinase
signal transduction pathway is activated by the endogenous cannabinoid anandamide.
FEBS Lett 359:133–136
Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at
hippocampal synapses. Nature 410:588–592
Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678–682
Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling
in the hippocampus. Neuron 31:453–462
Yamaji K, Sarker KP, Kawahara K, Iino S, Yamakuchi M, Abeyama K, Hashiguchi T,
Maruyama I (2003) Anandamide induces apoptosis in human endothelial cells: its
regulation system and clinical implications. Thromb Haemost 89:875–884
Zhou D, Song ZH (2001) CB1 cannabinoid receptor-mediated neurite remodeling in mouse
neuroblastoma N1E-115 cells. J Neurosci Res 65:346–353
Zhou D, Song ZH (2002) CB1 cannabinoid receptor-mediated tyrosine phosphorylation of
focal adhesion kinase-related non-kinase. FEBS Lett 525:164–168
Zhuang SY, Chen Y, Weiner JL, Hampson RE, Deadwyler SA (2003) Lack of functional
presynaptic,butputativepostsynapticactionsofcannabinoidsinhippocampalneurons.
Soc Neurosci Abstracts 29:462.1